Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
Employees - 22,
CEO - Mr. David A. Jenkins,
Sector - Healthcare,
Country - US,
Market Cap - 2.73M
Altman ZScore(max is 10): -15.99, Piotroski Score(max is 10): 2, Working Capital: $1207000, Total Assets: $27770000, Retained Earnings: $-292352000, EBIT: -11857000, Total Liabilities: $16013000, Revenue: $420000
- Current Price $0.29 - Analyst Target Price $2.00| Ticker | VTAK |
| Index | - |
| Curent Price | 0.29 |
| Change | 3.40% |
| Market Cap | 2.73M |
| Average Volume | 169.97K |
| Income | -21.80M |
| Sales | 0.42M |
| Book Value/Share | 1.47 |
| Cash/Share | 0.31 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 22 |
| Moving Avg 20days | -7.95% |
| Moving Avg 50days | -15.02% |
| Moving Avg 200days | -59.32% |
| Shares Outstanding | 9.27M |
| Earnings Date | Mar 28 BMO |
| Inst. Ownership | 5.18% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 6.50 |
| Price/Book | 0.20 |
| Price/Cash | 0.95 |
| Price/FCF | - |
| Quick Ratio | 1.56 |
| Current Ratio | 1.58 |
| Debt/Equity | 0.94 |
| Return on Assets | -56.89% |
| Return on Equity | -101.02% |
| Return on Investment | -96.97% |
| Gross Margin | -406.90% |
| Ops Margin | -2676.90% |
| Profit Margin | -5190.71% |
| RSI | 40.62 |
| BETA(β) | -0.87 |
| From 52week Low | 22.70% |
| From 52week High | -96.49% |
| EPS | -12.53 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | 83.47% |
| Sales past 5 Year | 565.58% |
| EPS Y/Y | 95.05% |
| Sales Y/Y | -4.98% |
| EPS Q/Q | -41.53% |
| Sales Q/Q | 16.41% |
| Sales Surprise | -4.00% |
| EPS Surprise | 8.64% |
| ATR(14) | 0.04 |
| Perf Week | -7.95% |
| Perf Month | -21.05% |
| Perf Quarter | -28.21% |
| Perf Year | -93.54% |
| Perf YTD | -34.71% |
| Target Price | 2.00 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer